Your browser doesn't support javascript.
loading
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy.
Grivas, Petros; Koshkin, Vadim S; Chu, Xiangying; Cole, Suzanne; Jain, Rohit K; Dreicer, Robert; Cetnar, Jeremy P; Sundi, Debasish; Gartrell, Benjamin A; Galsky, Matthew D; Woo, Brianna; Li-Ning-Tapia, Elsa; Hahn, Noah M; Carducci, Michael A.
Afiliação
  • Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA. Electronic address: pgrivas@uw.edu.
  • Koshkin VS; Helen Diller Family Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Chu X; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cole S; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Jain RK; H Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Dreicer R; University of Virginia Cancer Center, Charlottesville, VA, USA.
  • Cetnar JP; Oregon Health and Science University, Portland, OR, USA.
  • Sundi D; Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Gartrell BA; Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
  • Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Woo B; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.
  • Li-Ning-Tapia E; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hahn NM; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Carducci MA; Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Eur Urol Oncol ; 7(4): 914-922, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38155060
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Estudos de Viabilidade / Cisplatino / Terapia Neoadjuvante / Anticorpos Monoclonais Humanizados / Nivolumabe / Invasividade Neoplásica Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Estudos de Viabilidade / Cisplatino / Terapia Neoadjuvante / Anticorpos Monoclonais Humanizados / Nivolumabe / Invasividade Neoplásica Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article